retatrutide med express Contraindications: Risks and Considerations for Patients What is Retatrutide - Bangkok

About the author Maia Anderson Maia Anderson is a senior reporter at Healthcare Brew, where she focuses on pharma developments like GLP-1s and psychedelic medicine, pharmacies, and women's health.

Its the second daily oral medication to treat obesity and other weight-related conditions (Novo Nordisks oral Wegovy was the first) allowing patients to avoid having to give themselves injections

A phase 3 clinical trial for retatrutide is currently underway and expected to wrap up in May 2026

Photos of yourself from earlier years are also useful if your goal is to recapture a previous look

Schedule your consultation today and discover if GLP-1 therapy is right for your specific situation

The company, which ranked No